Do analysts rate ACXP or CPHI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Acurx Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 China Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Does the media favor ACXP or CPHI?

In the previous week, Acurx Pharmaceuticals had 1 more articles in the media than China Pharma. MarketBeat recorded 2 mentions for Acurx Pharmaceuticals and 1 mentions for China Pharma. Acurx Pharmaceuticals' average media sentiment score of 0.91 beat China Pharma's score of 0.23 indicating that Acurx Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Acurx Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive China Pharma 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate QNTM or ACXP?

Quantum Biopharma currently has a consensus price target of $8.00, suggesting a potential upside of 172.11%. Given Quantum Biopharma's higher probable upside, research analysts clearly believe Quantum Biopharma is more favorable than Acurx Pharmaceuticals. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Quantum Biopharma 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Acurx Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher earnings & valuation, QNTM or ACXP?

Quantum Biopharma is trading at a lower price-to-earnings ratio than Acurx Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Quantum Biopharma N/A N/A -$26.17M -$5.49 N/A Acurx Pharmaceuticals N/A N/A -$7.97M -$2.69 N/A

Is QNTM or ACXP more profitable?

Acurx Pharmaceuticals' return on equity of -124.73% beat Quantum Biopharma's return on equity. Company Net Margins Return on Equity Return on Assets Quantum Biopharma N/A -582.23% -184.20% Acurx Pharmaceuticals N/A -124.73% -87.48%

Does the media refer more to QNTM or ACXP?

In the previous week, Quantum Biopharma had 10 more articles in the media than Acurx Pharmaceuticals. MarketBeat recorded 12 mentions for Quantum Biopharma and 2 mentions for Acurx Pharmaceuticals. Acurx Pharmaceuticals' average media sentiment score of 0.91 beat Quantum Biopharma's score of 0.32 indicating that Acurx Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quantum Biopharma 0 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Acurx Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer ACXP or ABVC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Acurx Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 ABVC BioPharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is ACXP or ABVC more profitable?

ABVC BioPharma's return on equity of -47.68% beat Acurx Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Acurx Pharmaceuticals N/A -124.73% -87.48% ABVC BioPharma N/A -47.68% -30.97%

Do analysts rate ACXP or OPTH?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Acurx Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Optimi Health 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Is ACXP or OPTH more profitable?

Optimi Health's return on equity of 0.00% beat Acurx Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Acurx Pharmaceuticals N/A -124.73% -87.48% Optimi Health N/A N/A N/A

Does the media prefer ACXP or OPTH?

In the previous week, Optimi Health had 1 more articles in the media than Acurx Pharmaceuticals. MarketBeat recorded 3 mentions for Optimi Health and 2 mentions for Acurx Pharmaceuticals. Acurx Pharmaceuticals' average media sentiment score of 0.91 beat Optimi Health's score of 0.60 indicating that Acurx Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Acurx Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Optimi Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate TXMD or ACXP?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TherapeuticsMD 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Acurx Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media prefer TXMD or ACXP?

In the previous week, TherapeuticsMD had 2 more articles in the media than Acurx Pharmaceuticals. MarketBeat recorded 4 mentions for TherapeuticsMD and 2 mentions for Acurx Pharmaceuticals. Acurx Pharmaceuticals' average media sentiment score of 0.91 beat TherapeuticsMD's score of 0.46 indicating that Acurx Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TherapeuticsMD 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Acurx Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Acurx Pharmaceuticals (ACXP) Competitors

$1.27 0.00 (0.00%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$1.28 +0.01 (+0.71%)

As of 10/9/2026 07:59 PM Eastern

Compare

ACXP vs. CPHI, QNTM, ABVC, OPTH, and TXMD

Should you buy Acurx Pharmaceuticals stock or one of its competitors? Acurx Pharmaceuticals's main competitors and comparable companies include China Pharma (CPHI), Quantum Biopharma (QNTM), ABVC BioPharma (ABVC), Optimi Health (OPTH), and TherapeuticsMD (TXMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Acurx Pharmaceuticals compare to China Pharma?

Acurx Pharmaceuticals (NASDAQ:ACXP) and China Pharma (NYSE:CPHI) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

11.5% of Acurx Pharmaceuticals shares are owned by institutional investors. 6.5% of Acurx Pharmaceuticals shares are owned by insiders. Comparatively, 6.4% of China Pharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Acurx Pharmaceuticals had 1 more articles in the media than China Pharma. MarketBeat recorded 2 mentions for Acurx Pharmaceuticals and 1 mentions for China Pharma. Acurx Pharmaceuticals' average media sentiment score of 0.91 beat China Pharma's score of 0.23 indicating that Acurx Pharmaceuticals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Acurx Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
China Pharma	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Acurx Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
China Pharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

China Pharma has higher revenue and earnings than Acurx Pharmaceuticals. China Pharma is trading at a lower price-to-earnings ratio than Acurx Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acurx Pharmaceuticals	N/A	N/A	-$7.97M	-$2.69	N/A
China Pharma	$3.91M	9.57	-$3.08M	-$0.43	N/A

Acurx Pharmaceuticals has a beta of -2.05, indicating that its stock price is 305% less volatile than the broader market. Comparatively, China Pharma has a beta of 1.04, indicating that its stock price is 4% more volatile than the broader market.

Acurx Pharmaceuticals has a net margin of 0.00% compared to China Pharma's net margin of -85.56%. China Pharma's return on equity of -63.93% beat Acurx Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Acurx Pharmaceuticals	N/A	-124.73%	-87.48%
China Pharma	-85.56%	-63.93%	-31.42%

Summary

Acurx Pharmaceuticals beats China Pharma on 8 of the 14 factors compared between the two stocks.

How does Acurx Pharmaceuticals compare to Quantum Biopharma?

Quantum Biopharma (NASDAQ:QNTM) and Acurx Pharmaceuticals (NASDAQ:ACXP) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

Quantum Biopharma currently has a consensus price target of $8.00, suggesting a potential upside of 172.11%. Given Quantum Biopharma's higher probable upside, research analysts clearly believe Quantum Biopharma is more favorable than Acurx Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quantum Biopharma	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Acurx Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Quantum Biopharma is trading at a lower price-to-earnings ratio than Acurx Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quantum Biopharma	N/A	N/A	-$26.17M	-$5.49	N/A
Acurx Pharmaceuticals	N/A	N/A	-$7.97M	-$2.69	N/A

1.2% of Quantum Biopharma shares are owned by institutional investors. Comparatively, 11.5% of Acurx Pharmaceuticals shares are owned by institutional investors. 8.5% of Quantum Biopharma shares are owned by insiders. Comparatively, 6.5% of Acurx Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Acurx Pharmaceuticals' return on equity of -124.73% beat Quantum Biopharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quantum Biopharma	N/A	-582.23%	-184.20%
Acurx Pharmaceuticals	N/A	-124.73%	-87.48%

Quantum Biopharma has a beta of 0.39, meaning that its stock price is 61% less volatile than the broader market. Comparatively, Acurx Pharmaceuticals has a beta of -2.05, meaning that its stock price is 305% less volatile than the broader market.

In the previous week, Quantum Biopharma had 10 more articles in the media than Acurx Pharmaceuticals. MarketBeat recorded 12 mentions for Quantum Biopharma and 2 mentions for Acurx Pharmaceuticals. Acurx Pharmaceuticals' average media sentiment score of 0.91 beat Quantum Biopharma's score of 0.32 indicating that Acurx Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quantum Biopharma	0 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Acurx Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Acurx Pharmaceuticals beats Quantum Biopharma on 7 of the 11 factors compared between the two stocks.

How does Acurx Pharmaceuticals compare to ABVC BioPharma?

Acurx Pharmaceuticals (NASDAQ:ACXP) and ABVC BioPharma (NASDAQ:ABVC) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, analyst recommendations, dividends, valuation and profitability.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Acurx Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
ABVC BioPharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

11.5% of Acurx Pharmaceuticals shares are held by institutional investors. Comparatively, 11.4% of ABVC BioPharma shares are held by institutional investors. 6.5% of Acurx Pharmaceuticals shares are held by insiders. Comparatively, 19.0% of ABVC BioPharma shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

ABVC BioPharma has higher revenue and earnings than Acurx Pharmaceuticals. ABVC BioPharma is trading at a lower price-to-earnings ratio than Acurx Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acurx Pharmaceuticals	N/A	N/A	-$7.97M	-$2.69	N/A
ABVC BioPharma	$510K	52.33	-$7.91M	-$0.30	N/A

ABVC BioPharma's return on equity of -47.68% beat Acurx Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Acurx Pharmaceuticals	N/A	-124.73%	-87.48%
ABVC BioPharma	N/A	-47.68%	-30.97%

In the previous week, Acurx Pharmaceuticals had 1 more articles in the media than ABVC BioPharma. MarketBeat recorded 2 mentions for Acurx Pharmaceuticals and 1 mentions for ABVC BioPharma. Acurx Pharmaceuticals' average media sentiment score of 0.91 beat ABVC BioPharma's score of 0.89 indicating that Acurx Pharmaceuticals is being referred to more favorably in the media.

Company	Overall Sentiment
Acurx Pharmaceuticals	Positive
ABVC BioPharma	Positive

Acurx Pharmaceuticals has a beta of -2.05, suggesting that its share price is 305% less volatile than the broader market. Comparatively, ABVC BioPharma has a beta of 0.51, suggesting that its share price is 49% less volatile than the broader market.

Summary

ABVC BioPharma beats Acurx Pharmaceuticals on 7 of the 13 factors compared between the two stocks.

How does Acurx Pharmaceuticals compare to Optimi Health?

Acurx Pharmaceuticals (NASDAQ:ACXP) and Optimi Health (NASDAQ:OPTH) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment.

11.5% of Acurx Pharmaceuticals shares are owned by institutional investors. 6.5% of Acurx Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Optimi Health had 1 more articles in the media than Acurx Pharmaceuticals. MarketBeat recorded 3 mentions for Optimi Health and 2 mentions for Acurx Pharmaceuticals. Acurx Pharmaceuticals' average media sentiment score of 0.91 beat Optimi Health's score of 0.60 indicating that Acurx Pharmaceuticals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Acurx Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Optimi Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Acurx Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Optimi Health	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Optimi Health has higher revenue and earnings than Acurx Pharmaceuticals. Optimi Health is trading at a lower price-to-earnings ratio than Acurx Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acurx Pharmaceuticals	N/A	N/A	-$7.97M	-$2.69	N/A
Optimi Health	$310K	74.31	-$1.12M	-$0.76	N/A

Optimi Health's return on equity of 0.00% beat Acurx Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Acurx Pharmaceuticals	N/A	-124.73%	-87.48%
Optimi Health	N/A	N/A	N/A

Summary

Acurx Pharmaceuticals and Optimi Health tied by winning 6 of the 12 factors compared between the two stocks.

How does Acurx Pharmaceuticals compare to TherapeuticsMD?

TherapeuticsMD (NASDAQ:TXMD) and Acurx Pharmaceuticals (NASDAQ:ACXP) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, media sentiment, dividends, analyst recommendations, institutional ownership and profitability.

30.7% of TherapeuticsMD shares are held by institutional investors. Comparatively, 11.5% of Acurx Pharmaceuticals shares are held by institutional investors. 1.7% of TherapeuticsMD shares are held by company insiders. Comparatively, 6.5% of Acurx Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

TherapeuticsMD has higher revenue and earnings than Acurx Pharmaceuticals. Acurx Pharmaceuticals is trading at a lower price-to-earnings ratio than TherapeuticsMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TherapeuticsMD	$3.27M	7.29	-$570K	$0.02	103.00
Acurx Pharmaceuticals	N/A	N/A	-$7.97M	-$2.69	N/A

Acurx Pharmaceuticals has a net margin of 0.00% compared to TherapeuticsMD's net margin of -6.64%. TherapeuticsMD's return on equity of -1.09% beat Acurx Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TherapeuticsMD	-6.64%	-1.09%	-0.78%
Acurx Pharmaceuticals	N/A	-124.73%	-87.48%

In the previous week, TherapeuticsMD had 2 more articles in the media than Acurx Pharmaceuticals. MarketBeat recorded 4 mentions for TherapeuticsMD and 2 mentions for Acurx Pharmaceuticals. Acurx Pharmaceuticals' average media sentiment score of 0.91 beat TherapeuticsMD's score of 0.46 indicating that Acurx Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TherapeuticsMD	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Acurx Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TherapeuticsMD	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Acurx Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

TherapeuticsMD has a beta of 0.65, indicating that its stock price is 35% less volatile than the broader market. Comparatively, Acurx Pharmaceuticals has a beta of -2.05, indicating that its stock price is 305% less volatile than the broader market.

Summary

TherapeuticsMD beats Acurx Pharmaceuticals on 9 of the 14 factors compared between the two stocks.

Get Acurx Pharmaceuticals News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACXP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ACXP vs. The Competition

Export

Metric	Acurx Pharmaceuticals	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$7.06M	$12.43B	$7.26B	$13.29B
Dividend Yield	N/A	2.63%	2.52%	22.58%
P/E Ratio	-0.47	800.13	275.28	26.14
Price / Sales	N/A	754.45	577.70	83.21
Price / Cash	N/A	15.28	27.30	36.12
Price / Book	0.61	9.15	10.82	6.16
Net Income	-$7.97M	$2.84B	$3.50B	$381.12M
7 Day Performance	-3.05%	-0.88%	-1.19%	-1.43%
1 Month Performance	-9.29%	-3.66%	-4.00%	-3.36%
1 Year Performance	-83.02%	-3.95%	7.13%	1.49%

Acurx Pharmaceuticals Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ACXP Acurx Pharmaceuticals	1.8503 of 5 stars	$1.27 flat	N/A	-83.0%	$7.06M	N/A	N/A	4	Gap Down
CPHI China Pharma	N/A	$0.64 -1.8%	N/A	-52.2%	$27.58M	$3.91M	N/A	221	News Coverage Gap Down
QNTM Quantum Biopharma	1.8144 of 5 stars	$3.09 -5.5%	$8.00 +158.9%	-79.7%	$26.45M	N/A	N/A	7	News Coverage High Trading Volume
ABVC ABVC BioPharma	0.7505 of 5 stars	$0.97 -1.0%	N/A	-67.1%	$26.16M	$510K	N/A	19
OPTH Optimi Health	0.3319 of 5 stars	$4.13 -4.0%	N/A	N/A	$24.59M	$310K	N/A	9

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ACXP) was last updated on 10/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Acurx Pharmaceuticals (ACXP) Competitors

ACXP vs. CPHI, QNTM, ABVC, OPTH, and TXMD

How does Acurx Pharmaceuticals compare to China Pharma?

Summary

How does Acurx Pharmaceuticals compare to Quantum Biopharma?

Summary

How does Acurx Pharmaceuticals compare to ABVC BioPharma?

Summary

How does Acurx Pharmaceuticals compare to Optimi Health?

Summary

How does Acurx Pharmaceuticals compare to TherapeuticsMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACXP vs. The Competition

Acurx Pharmaceuticals Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Acurx Pharmaceuticals (ACXP) Competitors

ACXP vs. CPHI, QNTM, ABVC, OPTH, and TXMD

How does Acurx Pharmaceuticals compare to China Pharma?

Do institutionals and insiders hold more shares of ACXP or CPHI?

Does the media favor ACXP or CPHI?

Do analysts rate ACXP or CPHI?

Which has preferable earnings and valuation, ACXP or CPHI?

Which has more volatility & risk, ACXP or CPHI?

Is ACXP or CPHI more profitable?

Summary

How does Acurx Pharmaceuticals compare to Quantum Biopharma?

Do analysts rate QNTM or ACXP?

Which has higher earnings & valuation, QNTM or ACXP?

Do insiders & institutionals hold more shares of QNTM or ACXP?

Is QNTM or ACXP more profitable?

Which has more risk & volatility, QNTM or ACXP?

Does the media refer more to QNTM or ACXP?

Summary

How does Acurx Pharmaceuticals compare to ABVC BioPharma?

Do analysts prefer ACXP or ABVC?

Do insiders & institutionals believe in ACXP or ABVC?

Which has higher earnings & valuation, ACXP or ABVC?

Is ACXP or ABVC more profitable?

Does the media prefer ACXP or ABVC?

Which has more volatility & risk, ACXP or ABVC?

Summary

How does Acurx Pharmaceuticals compare to Optimi Health?

Do insiders & institutionals hold more shares of ACXP or OPTH?

Does the media prefer ACXP or OPTH?

Do analysts rate ACXP or OPTH?

Which has stronger valuation & earnings, ACXP or OPTH?

Is ACXP or OPTH more profitable?

Summary

How does Acurx Pharmaceuticals compare to TherapeuticsMD?

Do institutionals & insiders have more ownership in TXMD or ACXP?

Which has better valuation and earnings, TXMD or ACXP?

Is TXMD or ACXP more profitable?

Does the media prefer TXMD or ACXP?

Do analysts rate TXMD or ACXP?

Which has more volatility and risk, TXMD or ACXP?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACXP vs. The Competition

Acurx Pharmaceuticals Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools